prostate specific antigen

Related by string. Prostate Specific Antigen * Prostate . prostates . Prostates : Prostate Specific Antigen PSA . metastatic prostate cancer . Prostate Cancer Charity / specifi c . specifics . Specific : Specific Questions relating . Specific Plan . potently silencing specific / antigens . Antigen . Antigens : antigen presenting cells . specific membrane antigen . antigen sparing * *

Related by context. All words. (Click for frequent words.) 78 prostate specific 76 PSA prostate 75 Prostate Specific Antigen PSA 73 specific antigen 71 Prostate Specific Antigen 68 antigen PSA 68 serum PSA 66 PSA velocity 66 thyroid stimulating hormone 65 specific antigen PSA 64 serum prostate 62 C reactive protein 62 PSADT 61 Prostate specific antigen 61 PSA screening 61 cystatin C 61 fecal occult blood 61 digital rectal exam 61 antigen PSA levels 60 thyroglobulin 60 eGFR 60 #.#ng/ml 60 digital rectal examination 60 RBP4 60 PCa 59 adenoma 59 GnRH agonists 59 glomerular filtration rate 59 microalbuminuria 59 prostate cancer 59 MSMB 59 elevated CRP 59 serum creatinine 59 D dimer 59 albuminuria 59 prostate cancers 59 advanced neoplasia 58 aminotransferases 58 creatinine 58 prostate biopsy 58 serum creatinine levels 58 alanine aminotransferase ALT 58 C Reactive Protein 58 testosterone supplementation 58 asymptomatic carotid stenosis 58 hemoglobin A1C 58 SHBG 58 digital rectal exams 58 hydroxyvitamin D levels 58 serum testosterone 58 lactate dehydrogenase LDH 57 clinically insignificant 57 biochemical recurrence 57 thyroid stimulating hormone TSH 57 sarcosine 57 follicle stimulating hormone FSH 57 glycosylated hemoglobin 57 B7 H3 57 Lp PLA2 57 serum phosphate 57 hsCRP 57 urine albumin 57 c reactive protein 57 NMP# 57 HER2 expression 57 CaP 57 tPSA 57 glycated hemoglobin 57 hs CRP 57 fasting glucose 57 HbA1C 57 subclinical hyperthyroidism 57 PSA nadir 57 NT proBNP 57 serum potassium 57 atypical ductal hyperplasia 57 troponin T 57 Her2/neu 57 thyroxine 56 biopsies 56 carotid intima media 56 colorectal cancer 56 hemoglobin A1c 56 endoglin 56 intact parathyroid hormone 56 homocysteine levels 56 precancer 56 urine cytology 56 Inhibin B 56 fasting plasma glucose 56 elevated LDL cholesterol 56 Pap smear 56 Androgen deprivation therapy 56 F2 isoprostanes 56 glycated hemoglobin HbA1c 56 reticulocytes 56 prostate tumor 56 exhaled nitric oxide 56 N telopeptide 56 androgen deprivation therapy 56 Pap test 56 malondialdehyde 56 fasting blood glucose 56 creatinine levels 56 glycosylated hemoglobin HbA1c 56 colorectal adenoma 56 clusterin 56 undetectable PSA 56 dutasteride 56 orchiectomy 56 lipoprotein 56 prostate cancer PCa 56 androgen deficiency 56 localized prostate cancer 56 procalcitonin 56 prostate 56 immunochemical 55 statin medications 55 troponins 55 adiponectin levels 55 colorectal neoplasia 55 prostate tissue 55 EUS FNA 55 NGAL 55 serum calcium 55 atherogenic dyslipidemia 55 prostate cancer CaP 55 NMP# protein 55 coronary artery calcium 55 transferrin saturation 55 serum glucose 55 pCR 55 cTnT 55 seminoma 55 undergoing radical prostatectomy 55 aspartate aminotransferase AST 55 HbA1c 55 fecal occult 55 HGPIN 55 skin sterol 55 abnormal cytology 55 amino acid homocysteine 55 cTnI 55 peptide BNP 55 serum lipid levels 55 urate levels 55 grade cervical intraepithelial 55 serum thyroglobulin 55 platelet reactivity 55 iPTH 55 advanced adenoma 55 endometrial hyperplasia 55 enterolactone 55 radical prostatectomy RP 55 flexible sigmoidoscopy 55 fasting triglycerides 55 Estradiol 55 subclinical atherosclerosis 55 serum cortisol 55 microalbumin 55 intima media thickness 55 GSTP1 55 benign polyps 55 ERCC1 55 differentiated thyroid 55 glomerular filtration 54 HbA1c levels 54 guaiac 54 colorectal polyps 54 homocysteine concentrations 54 Lp PLA 2 54 PSA kinetics 54 alanine aminotransferase 54 HER2 overexpression 54 cTnT levels 54 adenomatous polyps 54 troponin 54 FDG PET 54 metastatic prostate cancer 54 epithelial ovarian cancer 54 undergo prostate biopsy 54 prostate biopsies 54 folate intake 54 serum IGF 54 HbA 1c 54 antihypertensive medications 54 homocysteine 54 microalbumin test 54 colorectal cancer CRC 54 KRAS mutation 54 PCA3 54 Clusterin 54 estimated glomerular filtration 54 intravenous bisphosphonates 54 spiral computed tomography 54 8 OHdG 54 Homocysteine 54 sFlt 1 54 renal dysfunction 54 uric acid levels 54 Ki# 54 serum urate 54 inflammatory biomarkers 54 undergone radical prostatectomy 54 neoplasia PIN 54 FDG-PET/CT 54 lactate dehydrogenase 54 DHEAS 54 ASCUS 54 deCODE BreastCancer TM 54 mammographic density 54 HAAH 54 cardiac troponin 54 renal cell carcinomas 54 colon polyps 54 fasting glucose levels 54 myeloperoxidase 54 thyroxine T4 54 #F FDG 54 postoperative mortality 54 fasting insulin 54 OGTT 54 Flexi Scope 54 serum calcium levels 54 serum IgE 54 dehydroepiandrosterone sulfate 54 A1c 54 cardiac troponin T 54 SUVmax 54 abdominal adiposity 53 mesothelin 53 protein albumin 53 SGPT 53 creatine kinase 53 elevated ALT 53 thyroid nodules 53 Prostate Cancer Prevention 53 CIN2 + 53 chronic prostatitis 53 androgen deprivation 53 androgenic hormones 53 Barrett esophagus 53 serum folate concentrations 53 urine NGAL 53 chlamydial infection 53 prostate cancer CRPC 53 Cotinine 53 serum CRP 53 serum estradiol 53 pmol L 53 cervical lesions 53 urinary symptoms 53 urine dipstick 53 thyrotropin 53 SHBG levels 53 paricalcitol 53 axillary lymph nodes 53 nuchal translucency 53 antibody titer 53 Corus CAD 53 ApoB 53 advanced adenomas 53 PCA3 scores 53 vitamin K1 53 serum ferritin 53 rheumatoid factor 53 proteinuria 53 estrogen metabolites 53 cortisol concentrations 53 plasma homocysteine 53 coronary calcification 53 serum urate levels 53 renal function 53 CK MB 53 SGOT 53 antidiabetic medication 53 screening mammography 53 urinary albumin 53 ptau 53 colorectal carcinoma 53 androgens 53 lipid lowering drugs 53 BRCA mutations 53 colorectal neoplasms 53 biochemical relapse 53 hemoglobin A1c HbA1c 53 Homocysteine levels 53 natriuretic peptides 53 Adenomas 53 Hb A1C 53 prostate tumors 53 albumin protein 53 aminotransferase ALT 53 ferritin 53 ductal cancer 53 aspartate aminotransferase 53 elevated serum creatinine 53 serum phosphorous 53 glycated hemoglobin levels 53 androgen suppression therapy 53 nonmelanoma skin cancers 53 serum concentrations 53 sitosterol 53 elevated homocysteine 53 albumin excretion 53 LHRH agonists 53 HER2 53 GnRH agonist 53 plasma selenium 53 serum uric acid 53 tHcy 53 biochemical markers 53 immunohistochemical 53 conventional coronary angiography 53 fetuin 53 maternal serum 53 elevated uric acid 53 aminotransferase levels 53 intensive statin therapy 53 neutrophil count 53 sweat chloride 53 basal cell nevus syndrome 52 DXA 52 F FDG PET 52 LDL Cholesterol 52 adiponectin 52 serum TSH 52 CT colonography 52 helical CT 52 postmenopausal hormone therapy 52 CIN3 + 52 grade gliomas 52 immunochemical fecal occult 52 fluorodeoxyglucose 52 transthyretin 52 cervical intraepithelial neoplasia 52 esophagogastroduodenoscopy 52 radioiodine therapy 52 PSA 52 overdiagnosis 52 soluble CD# ligand 52 preoperative PSA 52 overt hypothyroidism 52 clinically localized prostate 52 EBRT 52 aneuploidy 52 lipid abnormalities 52 adenomatous 52 IV bisphosphonates 52 insulin glargine 52 anti androgen 52 eosinophil count 52 endoxifen 52 biomarker 52 pre cancerous growths 52 D Dimer 52 HBV DNA levels 52 pleural fluid 52 thyroid hormone 52 Haptoglobin 52 precancerous tumors 52 B type natriuretic 52 hemoglobin hematocrit 52 nonfasting 52 Bone density 52 coronary artery calcification 52 estrogen receptor negative 52 coronary calcium 52 bioavailable testosterone 52 Rectal cancer 52 plasma folate 52 malignant polyps 52 ng mL 52 transient elastography 52 ductal breast cancer 52 urate 52 elevated creatinine 52 ankle brachial index 52 waist circumference 52 endometrial cancer 52 IGFBP 52 bladder tumors 52 malignant pleural mesothelioma 52 Hemoglobin A1C 52 prostate carcinoma 52 serum homocysteine 52 atypical hyperplasia 52 Cystatin C 52 FOLFOX4 52 lipid levels 52 bezafibrate 52 LHRH agonist 52 abnormal cervical 52 prostate TURP 52 familial ALS 52 transurethral resection 52 Digital Mammographic Imaging 52 triglyceride concentration 52 hydroxy vitamin D 52 perfusion MRI 52 cytologic 52 calculated creatinine clearance 52 AST ALT 52 abnormal mammogram 52 kidney function 52 bone resorption 52 protein excretion 52 oophorectomy 52 CD4 + cell 52 adenoma recurrence 52 oral antidiabetic medication 52 liver enzymes 52 test FOBT 52 gene amplification 52 hemoglobin A1c levels 52 prostate abnormalities 52 pre cancerous lesions 52 endometrial cancers 52 breast cancer recurrence 52 β amyloid 52 calcitriol 52 thickness CIMT 52 ADPKD 52 mitochondrial toxicity 52 prognostic indicator 52 colorectal adenomas 52 hematocrit 52 serum testosterone levels 52 invasive coronary angiography 52 Hemoglobin A1c 52 breast tumors 52 Fecal occult blood 52 thiazides 52 inflammatory markers 52 colonic polyps 52 adjuvant therapy 51 thiazide diuretics 51 selenium supplementation 51 urinary N telopeptide 51 sentinel lymph node biopsy 51 mRNA expression 51 mineral density BMD 51 CYP#C# [001] 51 DEXA 51 benign prostate 51 polyp detection 51 abnormal Pap test 51 inhibin B 51 PLCO 51 hydroxyvitamin D 51 adenomas 51 faecal occult blood 51 adjuvant radiotherapy 51 plasma leptin 51 subclinical hypothyroidism 51 apolipoprotein A1 51 lobular carcinoma 51 mm Hg systolic 51 hematopoietic cancers 51 gallstone disease 51 cardiorespiratory fitness 51 Telomere length 51 CT colonography CTC 51 intestinal polyps 51 Sentinel node biopsy 51 dietary modification 51 neoadjuvant therapy 51 EBUS FNA 51 antihypertensive therapy 51 hormone deprivation 51 esophageal adenocarcinoma 51 C telopeptide 51 HIV RNA 51 K ras mutations 51 lobular breast cancer 51 adjuvant radiation 51 A1C levels 51 neoadjuvant chemotherapy 51 colonoscopy screenings 51 radical prostatectomy 51 myopathy rhabdomyolysis 51 ng dL 51 varicocele 51 HDL Cholesterol 51 Prostate Lung Colorectal 51 ovarian hormones 51 node metastases 51 colon cancer 51 Getzenberg 51 alpha defensins 51 malignant nodules 51 luteinizing hormone LH 51 hormone therapy estrogen 51 serum biomarkers 51 immunoglobulin G 51 Creatinine 51 hematuria 51 methylmalonic acid 51 leukocyte count 51 thickness IMT 51 Fasting glucose 51 coronary angiography 51 galectin 3 51 mycophenolate mofetil 51 prostatic hyperplasia 51 triglycerides 51 total cholesterol LDL 51 CIN3 51 undetectable viral 51 methemoglobin 51 hsCRP levels 51 glucose 51 ursodeoxycholic acid 51 serum HBV DNA 51 precursor lesions 51 serum cholesterol 51 carcinoembryonic antigen 51 Epidermal Growth Factor Receptor 51 systolic pressure 51 adjuvant chemotherapy 51 Prehypertension 51 triiodothyronine 51 DEXA scan 51 ovarian cancer 51 telomere lengths 51 poor metabolizers 51 anti JCV antibodies 51 BRAF mutation 51 varicoceles 51 BSGI MBI 51 liver biopsy 51 follicle stimulating hormone 51 phylloquinone 51 liver enzyme 51 elevated blood glucose 51 alkaline phosphatase 51 mL/min/#.# m 2 51 anti Mullerian hormone 51 plasma lipid 51 AVODART 51 biopsy 51 triglyceride 51 hepatocellular carcinoma 51 folate deficiency 51 hormone human chorionic 51 transcranial Doppler 51 glargine 51 diagnose Alzheimer disease 51 sentinel node biopsy 51 Lipoprotein 51 urinary protein 51 lipid lowering medications 51 lymphocyte count 51 colorectal screening 51 RQ PCR 51 intravesical therapy 51 liver biopsies 51 LVEF 51 CPE delta N 51 Albuminuria 51 preoperative chemotherapy 51 CYP#D# 51 carotid stenosis 51 elevated LDH 51 micronuclei 51 colorectal polyp 51 serum clusterin levels 51 renal artery stenosis 51 Adjuvant chemotherapy 51 apoB 51 HNSCC 51 kidney dysfunction 51 cytological 51 Androgen Deprivation Therapy 51 core needle biopsies 51 PAP smear 51 serum selenium 51 alpha tocopherol 51 mU L 51 folate 51 BRCA mutation 51 cotinine 51 hypogonadal 51 serum parathyroid hormone 51 human chorionic gonadotropin hCG 51 noninvasive imaging 51 hamartomas 51 sensitivity specificity 51 Hyperlipidemia 51 folate supplementation 51 paraprotein 51 recurrent prostate cancer 51 HIV HCV coinfected 51 Recurrence Score 50 preeclampsia 50 grade dysplasia 50 prostatectomy 50 Fecal Occult Blood 50 pelvic lymphadenectomy 50 diabetic kidney 50 angiotensin receptor blockers ARBs 50 bevacizumab Avastin 50 overt nephropathy 50 fine needle aspiration 50 sentinel nodes 50 biochemical marker 50 precancerous lesions 50 cervical cancer precursors 50 Microalbuminuria 50 macroalbuminuria 50 angiotensin converting enzyme 50 neutrophil counts 50 pre cancerous polyps 50 DASH diet 50 axillary dissection 50 ubiquinone 50 prednisone prednisolone 50 colonoscopy sigmoidoscopy 50 abdominal computed tomography 50 plasma renin activity 50 silymarin 50 neoadjuvant 50 transaminases 50 urinary calcium 50 arterial thickening 50 Proteinuria 50 Amniocentesis 50 hyperphenylalaninemia HPA due 50 dysglycemia 50 BLLs 50 CLA supplementation 50 urinary oxalate 50 breast carcinomas 50 deCODE ProstateCancer TM 50 testicular germ cell 50 benign breast 50 NPH insulin 50 microvessel density 50 abnormal growths 50 Radical prostatectomy 50 superficial bladder cancer 50 colon tumors 50 FOBT 50 HDL triglycerides 50 UACR 50 chemosensitivity 50 nonfasting triglyceride levels 50 blood glucose 50 resected pancreatic cancer 50 pelvic ultrasound 50 imatinib Gleevec 50 alanine transaminase 50 endometrial carcinoma 50 malignant lesions 50 lymph node metastasis 50 aldosterone 50 lung nodules 50 naturally occurring estrogen 50 carotid IMT 50 blood phenylalanine Phe 50 Spironolactone 50 DHEA 50 oral glucose tolerance 50 p#INK#a 50 Elevated PSA 50 Sentinel Lymph Node Biopsy 50 antihypertensive drugs 50 luteinising hormone 50 prostate walnut 50 TSP1 50 external beam radiotherapy 50 isolated systolic hypertension 50 colonoscopy flexible sigmoidoscopy 50 micrometastases 50 A1C 50 serum bicarbonate 50 Colorectal cancer screening 50 nonalcoholic steatohepatitis NASH 50 SCr 50 breast carcinoma 50 colorectal liver metastases 50 triglyceride concentrations 50 postoperative chemotherapy 50 serum sodium 50 rs# [002] 50 tumor recurrence 50 echocardiographic 50 leiomyomas 50 Androgen 50 asymptomatic 50 adrenal function 50 triacylglycerol concentrations 50 underwent radical prostatectomy 50 urothelial carcinoma 50 sustained virological response 50 Peptide YY 50 acute humoral rejection 50 5-FU/LV 50 NMIBC 50 pre menopausal 50 serum lipid 50 Bladder Cancer 50 dose Iluvien 50 dose clopidogrel 50 epithelial tumors 50 alpha fetoprotein AFP 50 triglyceride levels 50 PROLARIS 50 renal tumors 50 metastatic castration resistant 50 BRAF mutations 50 #ng/ml 50 primary aldosteronism 50 postoperative pulmonary 50 PlGF 50 highest tertile 50 irbesartan 50 perimenopausal women 50 detectable BPA 50 subclinical disease 50 relapsed MM 50 leukocytosis 50 pancreatic polypeptide 50 LDL cholesterol 50 elevated triglycerides 50 thyroid hormone levels 50 MDRD equation 50 cystoscopy 50 Prognostic 50 bicalutamide 50 male hormones androgens 50 potentially cancerous growths 50 albumin excretion rate 50 biomarkers 50 LRP5 50 BENICAR HCT 50 benign prostatic hyperplasia enlarged 50 RBP4 levels 50 bowel polyps 50 antihypertensive medication 50 genistein 50 parathyroidectomy 50 lipoprotein Lp 50 blood sugar 50 neoplasia 50 soy isoflavones 50 thyrotropin levels 50 core needle biopsy 50 screening colonoscopy 50 catheter angiography 50 bladder cancers 50 testicular cancers 50 Prostate Cancer Progression 50 histopathologic examination 50 breast endometrial 50 anthracyclines 50 aldosterone antagonist 50 thyroid function 50 Lymph node 50 β blockers 50 multivariable analysis 50 KRAS mutations 50 fFN 50 DEXA scans 50 invasive lobular carcinoma 50 incidentalomas 50 leukocyte counts 50 serous ovarian cancer 50 radiotracer 50 ethyl glucuronide 50 NQO1 50 androgen hormone 50 lipid elevations 50 colorectal tumors 50 urolithiasis 50 Septin9 50 hyperplasia 50 CHD mortality 50 bilirubin levels 50 index BMI 50 endometrial thickness 50 pulmonary angiography 50 atypia 50 lymphocyte counts 50 synthetic thyroid hormone 50 axillary lymph node 50 polyp recurrence 50 GPx 50 estrogen progesterone 50 serum leptin 50 Barrett Esophagus 50 HER2 amplification 50 risk stratification 50 hypercholesterolaemia 50 malignant growths 50 conventional cytology 50 FeNO 50 calcitonin 50 gamma tocopherol 50 pT2 49 transrectal ultrasound guided 49 luteinising hormone LH 49 cytoreductive nephrectomy 49 hydroxyvitamin D concentrations 49 colorectal cancers 49 endogenous EPO 49 cholesterol 49 transgene expression 49 fasting plasma glucose FPG 49 colorectal carcinomas 49 guaiac test 49 axillary node dissection 49 hormonal therapy 49 Prognostic Value 49 transvaginal ultrasound 49 Gonadotropin 49 multivariate Cox 49 poorer prognosis 49 A2 Lp PLA2 49 PET scans 49 sUA 49 IgG antibody 49 transaminase levels 49 ELISpot 49 surgical biopsy 49 insulin detemir 49 cranial irradiation 49 NNRTI resistance 49 malondialdehyde MDA 49 trans palmitoleic acid 49 PIK3CA 49 hydroxychloroquine 49 amyloid deposition 49 glycosylated hemoglobin levels 49 A1c levels 49 IGFBP 3 49 fulvestrant 49 non squamous NSCLC 49 nonmelanoma skin cancer 49 stone formers 49 myocardial uptake 49 immunosuppressive agents 49 tibolone 49 Rh factor 49 diabetes mellitus DM 49 BEXXAR Therapeutic Regimen 49 MGUS 49 ACh 49 diuretic hydrochlorothiazide 49 Leitzmann 49 PSA Prostate Specific 49 urinary excretion 49 hypertensives 49 colorectal cancer screening 49 serum triglyceride 49 serum triglycerides 49 TNFa 49 precancerous growths 49 bad cholesterol LDL 49 prostate enlarges 49 carotid artery intima media 49 metastatic lesions 49 loop diuretics 49 anogenital distance 49 tamoxifen 49 TOP2A 49 serum albumin 49 fructose diet 49 biopsied tissue 49 platelet aggregation 49 surgical biopsies 49 nutlin 3a 49 plasma triglycerides 49 colonoscopy 49 malignancy 49 ImmuKnow 49 NP CRNs 49 NAFLD 49 excisional biopsy 49 triacylglycerol 49 sigmoidoscopy 49 interferon gamma 49 CD4 cell 49 prostates 49 lipid lowering therapy 49 oxycholesterol 49 T2DM 49 rectal cancers 49 Framingham Risk Score 49 cholesterol LDL C 49 HbF 49 serum GGT 49 flutamide 49 fructosamine 49 intraocular pressure IOP 49 antitumor effect 49 PGDH 49 bone density measurements 49 glulisine 49 soluble endoglin 49 fluvastatin 49 VerifyNow 49 methylation markers 49 somatostatin analogs 49 proton MR spectroscopy 49 plasma homocysteine levels 49 phthalate metabolites 49 Invasive Breast Cancer 49 Stop Hypertension DASH diet 49 Screening Trial DMIST 49 ovarian malignancy 49 ng ml 49 breast cancers 49 castration resistant prostate cancer 49 arterial stiffening 49 colorectal cancer screenings 49 esophageal carcinoma 49 CD4 counts 49 benign proliferative breast 49 hormone 49 calcium supplementation 49 Immunohistochemistry 49 ductal carcinoma 49 serum phosphate levels 49 NNAL 49 recurrent VTE 49 arterial oxygen saturation 49 overtreatment 49 premalignant lesion 49 nelfinavir 49 lymph node biopsies 49 pelvic malignancies 49 HER2 gene 49 pg mL 49 metastatic renal cell carcinoma 49 Skin sterol 49 VEGF expression 49 fasting lipid 49 estradiol 49 LDL cholesterol levels 49 Hashimoto thyroiditis 49 ovarian carcinoma 49 endosonography 49 hematologic parameters 49 finasteride 49 prognostic 49 precancerous cervical lesions 49 flavopiridol 49 KRAS variant 49 urothelial cancer 49 glycemia 49 interleukin IL -# 49 apolipoprotein B 49 FISH fluorescence 49 pheochromocytomas 49 chest radiographs 49 premalignant lesions 49 Metastases 49 erythrocyte sedimentation rate 49 fructose intake 49 HER-2/neu 49 alpha carotene 49 beta blocker therapy 49 MLH1 49 phosphorylated tau 49 CVD mortality 49 atherosclerotic disease 49 mm Hg diastolic 49 miRNA expression 49 fecal immunochemical test 49 abnormal lipid 49 cytology 49 lymph node metastases 49 bowel cancers 49 bladder carcinoma 49 palmitoleate 49 lobular cancer 49 radical nephrectomy 49 blood urea nitrogen 49 telomerase activation 49 adrenal suppression 49 androgen suppression 49 serum aminotransferase levels 49 gastric carcinoma 49 IgA 49 grade prostatic intraepithelial 49 colorectal cancer incidence 49 μmol L 49 hypothyroidism 49 prognostic significance 49 serum triglyceride levels 49 screening colonoscopies 49 mineral density 49 fosamprenavir 49 metabolic parameters 49 pharmacologic stress 49 d dimer 49 antioxidant supplementation 49 barium enema

Back to home page